0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.16%
Revenue growth under 50% of 0425.HK's 9.01%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
20.10%
Positive gross profit growth while 0425.HK is negative. John Neff would see a clear operational edge over the competitor.
8.18%
Positive EBIT growth while 0425.HK is negative. John Neff might see a substantial edge in operational management.
8.18%
Positive operating income growth while 0425.HK is negative. John Neff might view this as a competitive edge in operations.
85.09%
Positive net income growth while 0425.HK is negative. John Neff might see a big relative performance advantage.
84.38%
Positive EPS growth while 0425.HK is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
85.94%
Positive diluted EPS growth while 0425.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-6.85%
Share reduction while 0425.HK is at 0.03%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
1.22%
Slight or no buyback while 0425.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
6.96%
Maintaining or increasing dividends while 0425.HK cut them. John Neff might see a strong edge in shareholder returns.
-10.98%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-15.47%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-35.10%
Negative 10Y revenue/share CAGR while 0425.HK stands at 212.98%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-46.64%
Negative 5Y CAGR while 0425.HK stands at 38.10%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-44.46%
Negative 3Y CAGR while 0425.HK stands at 10.02%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-8146.73%
Negative 10Y OCF/share CAGR while 0425.HK stands at 41.19%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
36.76%
Positive OCF/share growth while 0425.HK is negative. John Neff might see a comparative advantage in operational cash viability.
-85.39%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-196.54%
Negative 10Y net income/share CAGR while 0425.HK is at 23.99%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-102.54%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-108.70%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
88.86%
10Y equity/share CAGR at 50-75% of 0425.HK's 145.68%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
-3.72%
Negative 5Y equity/share growth while 0425.HK is at 49.68%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-12.03%
Negative 3Y equity/share growth while 0425.HK is at 21.06%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-18.72%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.37%
AR growth is negative/stable vs. 0425.HK's 22.36%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
20.84%
Inventory growth well above 0425.HK's 12.32%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.58%
Asset growth at 50-75% of 0425.HK's 5.13%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
5.91%
1.25-1.5x 0425.HK's 5.01%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-3.03%
We’re deleveraging while 0425.HK stands at 0.71%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
146.15%
R&D growth drastically higher vs. 0425.HK's 20.07%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-18.01%
We cut SG&A while 0425.HK invests at 13.49%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.